<DOC>
	<DOCNO>NCT00184561</DOCNO>
	<brief_summary>This trial conduct Asia . This clinical trial investigate effectiveness use Biphasic Insulin Aspart 70/30 two different treatment regiment 6 month subject type 2 diabetes , well control current oral anti-diabetic drug therapy .</brief_summary>
	<brief_title>Effectiveness Safety Biphasic Insulin Aspart 70/30 Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 2 diabetes HbA1C = 7.5 % Insulin na√Øve Current treatment Oral Antidiabetic Drugs Severe medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>